1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Congenital Heart Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Medication 1.2.3 Surgical Therapy 1.3 Market by Application 1.3.1 Global Congenital Heart Disease Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals and clinics 1.3.3 Diagnostic centres 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Congenital Heart Disease Market Perspective (2016-2027) 2.2 Congenital Heart Disease Growth Trends by Regions 2.2.1 Congenital Heart Disease Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Congenital Heart Disease Historic Market Share by Regions (2016-2021) 2.2.3 Congenital Heart Disease Forecasted Market Size by Regions (2022-2027) 2.3 Congenital Heart Disease Industry Dynamic 2.3.1 Congenital Heart Disease Market Trends 2.3.2 Congenital Heart Disease Market Drivers 2.3.3 Congenital Heart Disease Market Challenges 2.3.4 Congenital Heart Disease Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Congenital Heart Disease Players by Revenue 3.1.1 Global Top Congenital Heart Disease Players by Revenue (2016-2021) 3.1.2 Global Congenital Heart Disease Revenue Market Share by Players (2016-2021) 3.2 Global Congenital Heart Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Congenital Heart Disease Revenue 3.4 Global Congenital Heart Disease Market Concentration Ratio 3.4.1 Global Congenital Heart Disease Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Congenital Heart Disease Revenue in 2020 3.5 Congenital Heart Disease Key Players Head office and Area Served 3.6 Key Players Congenital Heart Disease Product Solution and Service 3.7 Date of Enter into Congenital Heart Disease Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Congenital Heart Disease Breakdown Data by Type 4.1 Global Congenital Heart Disease Historic Market Size by Type (2016-2021) 4.2 Global Congenital Heart Disease Forecasted Market Size by Type (2022-2027) 5 Congenital Heart Disease Breakdown Data by Application 5.1 Global Congenital Heart Disease Historic Market Size by Application (2016-2021) 5.2 Global Congenital Heart Disease Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Congenital Heart Disease Market Size (2016-2027) 6.2 North America Congenital Heart Disease Market Size by Type 6.2.1 North America Congenital Heart Disease Market Size by Type (2016-2021) 6.2.2 North America Congenital Heart Disease Market Size by Type (2022-2027) 6.2.3 North America Congenital Heart Disease Market Size by Type (2016-2027) 6.3 North America Congenital Heart Disease Market Size by Application 6.3.1 North America Congenital Heart Disease Market Size by Application (2016-2021) 6.3.2 North America Congenital Heart Disease Market Size by Application (2022-2027) 6.3.3 North America Congenital Heart Disease Market Size by Application (2016-2027) 6.4 North America Congenital Heart Disease Market Size by Country 6.4.1 North America Congenital Heart Disease Market Size by Country (2016-2021) 6.4.2 North America Congenital Heart Disease Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Congenital Heart Disease Market Size (2016-2027) 7.2 Europe Congenital Heart Disease Market Size by Type 7.2.1 Europe Congenital Heart Disease Market Size by Type (2016-2021) 7.2.2 Europe Congenital Heart Disease Market Size by Type (2022-2027) 7.2.3 Europe Congenital Heart Disease Market Size by Type (2016-2027) 7.3 Europe Congenital Heart Disease Market Size by Application 7.3.1 Europe Congenital Heart Disease Market Size by Application (2016-2021) 7.3.2 Europe Congenital Heart Disease Market Size by Application (2022-2027) 7.3.3 Europe Congenital Heart Disease Market Size by Application (2016-2027) 7.4 Europe Congenital Heart Disease Market Size by Country 7.4.1 Europe Congenital Heart Disease Market Size by Country (2016-2021) 7.4.2 Europe Congenital Heart Disease Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Congenital Heart Disease Market Size (2016-2027) 8.2 Asia-Pacific Congenital Heart Disease Market Size by Type 8.2.1 Asia-Pacific Congenital Heart Disease Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Congenital Heart Disease Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Congenital Heart Disease Market Size by Type (2016-2027) 8.3 Asia-Pacific Congenital Heart Disease Market Size by Application 8.3.1 Asia-Pacific Congenital Heart Disease Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Congenital Heart Disease Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Congenital Heart Disease Market Size by Application (2016-2027) 8.4 Asia-Pacific Congenital Heart Disease Market Size by Region 8.4.1 Asia-Pacific Congenital Heart Disease Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Congenital Heart Disease Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Congenital Heart Disease Market Size (2016-2027) 9.2 Latin America Congenital Heart Disease Market Size by Type 9.2.1 Latin America Congenital Heart Disease Market Size by Type (2016-2021) 9.2.2 Latin America Congenital Heart Disease Market Size by Type (2022-2027) 9.2.3 Latin America Congenital Heart Disease Market Size by Type (2016-2027) 9.3 Latin America Congenital Heart Disease Market Size by Application 9.3.1 Latin America Congenital Heart Disease Market Size by Application (2016-2021) 9.3.2 Latin America Congenital Heart Disease Market Size by Application (2022-2027) 9.3.3 Latin America Congenital Heart Disease Market Size by Application (2016-2027) 9.4 Latin America Congenital Heart Disease Market Size by Country 9.4.1 Latin America Congenital Heart Disease Market Size by Country (2016-2021) 9.4.2 Latin America Congenital Heart Disease Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Congenital Heart Disease Market Size (2016-2027) 10.2 Middle East & Africa Congenital Heart Disease Market Size by Type 10.2.1 Middle East & Africa Congenital Heart Disease Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Congenital Heart Disease Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Congenital Heart Disease Market Size by Type (2016-2027) 10.3 Middle East & Africa Congenital Heart Disease Market Size by Application 10.3.1 Middle East & Africa Congenital Heart Disease Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Congenital Heart Disease Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Congenital Heart Disease Market Size by Application (2016-2027) 10.4 Middle East & Africa Congenital Heart Disease Market Size by Country 10.4.1 Middle East & Africa Congenital Heart Disease Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Congenital Heart Disease Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Congenital Heart Disease Introduction 11.1.4 Pfizer Revenue in Congenital Heart Disease Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Congenital Heart Disease Introduction 11.2.4 Novartis Revenue in Congenital Heart Disease Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Abbott Laboratories 11.3.1 Abbott Laboratories Company Details 11.3.2 Abbott Laboratories Business Overview 11.3.3 Abbott Laboratories Congenital Heart Disease Introduction 11.3.4 Abbott Laboratories Revenue in Congenital Heart Disease Business (2016-2021) 11.3.5 Abbott Laboratories Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Congenital Heart Disease Introduction 11.4.4 Roche Revenue in Congenital Heart Disease Business (2016-2021) 11.4.5 Roche Recent Development 11.5 GSK 11.5.1 GSK Company Details 11.5.2 GSK Business Overview 11.5.3 GSK Congenital Heart Disease Introduction 11.5.4 GSK Revenue in Congenital Heart Disease Business (2016-2021) 11.5.5 GSK Recent Development 11.6 Sanofi 11.6.1 Sanofi Company Details 11.6.2 Sanofi Business Overview 11.6.3 Sanofi Congenital Heart Disease Introduction 11.6.4 Sanofi Revenue in Congenital Heart Disease Business (2016-2021) 11.6.5 Sanofi Recent Development 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Details 11.7.2 Johnson & Johnson Business Overview 11.7.3 Johnson & Johnson Congenital Heart Disease Introduction 11.7.4 Johnson & Johnson Revenue in Congenital Heart Disease Business (2016-2021) 11.7.5 Johnson & Johnson Recent Development 11.8 Medtronic 11.8.1 Medtronic Company Details 11.8.2 Medtronic Business Overview 11.8.3 Medtronic Congenital Heart Disease Introduction 11.8.4 Medtronic Revenue in Congenital Heart Disease Business (2016-2021) 11.8.5 Medtronic Recent Development 11.9 BD 11.9.1 BD Company Details 11.9.2 BD Business Overview 11.9.3 BD Congenital Heart Disease Introduction 11.9.4 BD Revenue in Congenital Heart Disease Business (2016-2021) 11.9.5 BD Recent Development 11.10 Boston Scientific 11.10.1 Boston Scientific Company Details 11.10.2 Boston Scientific Business Overview 11.10.3 Boston Scientific Congenital Heart Disease Introduction 11.10.4 Boston Scientific Revenue in Congenital Heart Disease Business (2016-2021) 11.10.5 Boston Scientific Recent Development 11.11 Merck 11.11.1 Merck Company Details 11.11.2 Merck Business Overview 11.11.3 Merck Congenital Heart Disease Introduction 11.11.4 Merck Revenue in Congenital Heart Disease Business (2016-2021) 11.11.5 Merck Recent Development 11.12 Eli Lilly 11.12.1 Eli Lilly Company Details 11.12.2 Eli Lilly Business Overview 11.12.3 Eli Lilly Congenital Heart Disease Introduction 11.12.4 Eli Lilly Revenue in Congenital Heart Disease Business (2016-2021) 11.12.5 Eli Lilly Recent Development 11.13 Mylan 11.13.1 Mylan Company Details 11.13.2 Mylan Business Overview 11.13.3 Mylan Congenital Heart Disease Introduction 11.13.4 Mylan Revenue in Congenital Heart Disease Business (2016-2021) 11.13.5 Mylan Recent Development 11.14 Sun Pharmaceutical 11.14.1 Sun Pharmaceutical Company Details 11.14.2 Sun Pharmaceutical Business Overview 11.14.3 Sun Pharmaceutical Congenital Heart Disease Introduction 11.14.4 Sun Pharmaceutical Revenue in Congenital Heart Disease Business (2016-2021) 11.14.5 Sun Pharmaceutical Recent Development 11.15 AstraZeneca 11.15.1 AstraZeneca Company Details 11.15.2 AstraZeneca Business Overview 11.15.3 AstraZeneca Congenital Heart Disease Introduction 11.15.4 AstraZeneca Revenue in Congenital Heart Disease Business (2016-2021) 11.15.5 AstraZeneca Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Congenital Heart Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Medication Table 3. Key Players of Surgical Therapy Table 4. Global Congenital Heart Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Congenital Heart Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Congenital Heart Disease Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Congenital Heart Disease Market Share by Regions (2016-2021) Table 8. Global Congenital Heart Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Congenital Heart Disease Market Share by Regions (2022-2027) Table 10. Congenital Heart Disease Market Trends Table 11. Congenital Heart Disease Market Drivers Table 12. Congenital Heart Disease Market Challenges Table 13. Congenital Heart Disease Market Restraints Table 14. Global Congenital Heart Disease Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Congenital Heart Disease Market Share by Players (2016-2021) Table 16. Global Top Congenital Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congenital Heart Disease as of 2020) Table 17. Ranking of Global Top Congenital Heart Disease Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Congenital Heart Disease Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Congenital Heart Disease Product Solution and Service Table 21. Date of Enter into Congenital Heart Disease Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million) Table 24. Global Congenital Heart Disease Revenue Market Share by Type (2016-2021) Table 25. Global Congenital Heart Disease Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Congenital Heart Disease Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Congenital Heart Disease Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Congenital Heart Disease Revenue Market Share by Application (2016-2021) Table 29. Global Congenital Heart Disease Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Congenital Heart Disease Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million) Table 32. North America Congenital Heart Disease Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Congenital Heart Disease Market Size by Application (2016-2021) (US$ Million) Table 34. North America Congenital Heart Disease Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Congenital Heart Disease Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Congenital Heart Disease Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Congenital Heart Disease Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Congenital Heart Disease Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Congenital Heart Disease Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Congenital Heart Disease Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Congenital Heart Disease Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Congenital Heart Disease Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Congenital Heart Disease Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Congenital Heart Disease Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Congenital Heart Disease Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Congenital Heart Disease Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Congenital Heart Disease Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Congenital Heart Disease Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Congenital Heart Disease Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Congenital Heart Disease Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Congenital Heart Disease Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Congenital Heart Disease Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Congenital Heart Disease Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Congenital Heart Disease Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Congenital Heart Disease Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Congenital Heart Disease Market Size by Country (2022-2027) & (US$ Million) Table 61. Pfizer Company Details Table 62. Pfizer Business Overview Table 63. Pfizer Congenital Heart Disease Product Table 64. Pfizer Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 65. Pfizer Recent Development Table 66. Novartis Company Details Table 67. Novartis Business Overview Table 68. Novartis Congenital Heart Disease Product Table 69. Novartis Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 70. Novartis Recent Development Table 71. Abbott Laboratories Company Details Table 72. Abbott Laboratories Business Overview Table 73. Abbott Laboratories Congenital Heart Disease Product Table 74. Abbott Laboratories Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 75. Abbott Laboratories Recent Development Table 76. Roche Company Details Table 77. Roche Business Overview Table 78. Roche Congenital Heart Disease Product Table 79. Roche Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 80. Roche Recent Development Table 81. GSK Company Details Table 82. GSK Business Overview Table 83. GSK Congenital Heart Disease Product Table 84. GSK Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 85. GSK Recent Development Table 86. Sanofi Company Details Table 87. Sanofi Business Overview Table 88. Sanofi Congenital Heart Disease Product Table 89. Sanofi Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 90. Sanofi Recent Development Table 91. Johnson & Johnson Company Details Table 92. Johnson & Johnson Business Overview Table 93. Johnson & Johnson Congenital Heart Disease Product Table 94. Johnson & Johnson Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 95. Johnson & Johnson Recent Development Table 96. Medtronic Company Details Table 97. Medtronic Business Overview Table 98. Medtronic Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 99. Medtronic Recent Development Table 100. BD Company Details Table 101. BD Business Overview Table 102. BD Congenital Heart Disease Product Table 103. BD Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 104. BD Recent Development Table 105. Boston Scientific Company Details Table 106. Boston Scientific Business Overview Table 107. Boston Scientific Congenital Heart Disease Product Table 108. Boston Scientific Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 109. Boston Scientific Recent Development Table 110. Merck Company Details Table 111. Merck Business Overview Table 112. Merck Congenital Heart Disease Product Table 113. Merck Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 114. Merck Recent Development Table 115. Eli Lilly Company Details Table 116. Eli Lilly Business Overview Table 117. Eli Lilly Congenital Heart Disease Product Table 118. Eli Lilly Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 119. Eli Lilly Recent Development Table 120. Mylan Company Details Table 121. Mylan Business Overview Table 122. Mylan Congenital Heart Disease Product Table 123. Mylan Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 124. Mylan Recent Development Table 125. Sun Pharmaceutical Company Details Table 126. Sun Pharmaceutical Business Overview Table 127. Sun Pharmaceutical Congenital Heart Disease Product Table 128. Sun Pharmaceutical Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 129. Sun Pharmaceutical Recent Development Table 130. AstraZeneca Company Details Table 131. AstraZeneca Business Overview Table 132. AstraZeneca Congenital Heart Disease Product Table 133. AstraZeneca Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million) Table 134. AstraZeneca Recent Development Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global Congenital Heart Disease Market Share by Type: 2020 VS 2027 Figure 2. Medication Features Figure 3. Surgical Therapy Features Figure 4. Global Congenital Heart Disease Market Share by Application: 2020 VS 2027 Figure 5. Hospitals and clinics Case Studies Figure 6. Diagnostic centres Case Studies Figure 7. Congenital Heart Disease Report Years Considered Figure 8. Global Congenital Heart Disease Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 9. Global Congenital Heart Disease Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Congenital Heart Disease Market Share by Regions: 2020 VS 2027 Figure 11. Global Congenital Heart Disease Market Share by Regions (2022-2027) Figure 12. Global Congenital Heart Disease Market Share by Players in 2020 Figure 13. Global Top Congenital Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congenital Heart Disease as of 2020 Figure 14. The Top 10 and 5 Players Market Share by Congenital Heart Disease Revenue in 2020 Figure 15. Global Congenital Heart Disease Revenue Market Share by Type (2016-2021) Figure 16. Global Congenital Heart Disease Revenue Market Share by Type (2022-2027) Figure 17. North America Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 18. North America Congenital Heart Disease Market Share by Type (2016-2027) Figure 19. North America Congenital Heart Disease Market Share by Application (2016-2027) Figure 20. North America Congenital Heart Disease Market Share by Country (2016-2027) Figure 21. United States Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. Canada Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Europe Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Congenital Heart Disease Market Share by Type (2016-2027) Figure 25. Europe Congenital Heart Disease Market Share by Application (2016-2027) Figure 26. Europe Congenital Heart Disease Market Share by Country (2016-2027) Figure 27. Germany Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. France Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. U.K. Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Italy Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Russia Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Nordic Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Asia-Pacific Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Congenital Heart Disease Market Share by Type (2016-2027) Figure 35. Asia-Pacific Congenital Heart Disease Market Share by Application (2016-2027) Figure 36. Asia-Pacific Congenital Heart Disease Market Share by Region (2016-2027) Figure 37. China Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Japan Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. South Korea Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Southeast Asia Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. India Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Australia Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Latin America Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Congenital Heart Disease Market Share by Type (2016-2027) Figure 45. Latin America Congenital Heart Disease Market Share by Application (2016-2027) Figure 46. Latin America Congenital Heart Disease Market Share by Country (2016-2027) Figure 47. Mexico Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Brazil Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Middle East & Africa Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Congenital Heart Disease Market Share by Type (2016-2027) Figure 51. Middle East & Africa Congenital Heart Disease Market Share by Application (2016-2027) Figure 52. Middle East & Africa Congenital Heart Disease Market Share by Country (2016-2027) Figure 53. Turkey Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Saudi Arabia Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. UAE Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Pfizer Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 57. Novartis Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 58. Abbott Laboratories Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 59. Roche Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 60. GSK Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 61. Sanofi Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 62. Johnson & Johnson Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 63. Medtronic Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 64. BD Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 65. Boston Scientific Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 66. Merck Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 67. Eli Lilly Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 68. Mylan Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 69. Sun Pharmaceutical Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 70. AstraZeneca Revenue Growth Rate in Congenital Heart Disease Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Pfizer Novartis Abbott Laboratories Roche GSK Sanofi Johnson & Johnson Medtronic BD Boston Scientific Merck Eli Lilly Mylan Sun Pharmaceutical AstraZeneca